Targeting gastrin releasing peptide receptors: New options for the therapy and diagnosis of cancer.

Hohla, F; Schally, AV; Cell Cycle. 2010; 9(9): 1738-1741.

Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients.

Sterlacci, W; Fiegl, M; Hilbe, W; Jamnig, H; Oberaigner, W; Schmid, T; Augustin, F; Auberger, J; Obermann, EC; Tzankov, A; J Thorac Oncol. 2010; 5(9): 1325-1336.

CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B

Leick, M; Catusse, J; Follo, M; Nibbs, RJ; Hartmann, TN; Veelken, H; Burger, M IMMUNOLOGY. 2010; 129(4): 536-546.

PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis.

Wasim, M; Carlet, M; Mansha, M; Greil, R; Ploner, C; Trockenbacher, A; Rainer, J; Kofler, R J STEROID BIOCHEM. 2010; 120(4-5): 218-227.

Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia.

Merkel, O; Asslaber, D; Piñón, JD; Egle, A; Greil, R; Cell Cycle. 2010; 9(14):2764-2768

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin“s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Eich, HT; Diehl, V; Görgen, H; Pabst, T; Markova, J; Debus, J; Ho, A; Dörken, B; Rank, A; Grosu, AL; Wiegel, T; Karstens, JH; Greil, R; Willich, N; Schmidberger, H; Döhner, H; Borchmann, P; Müller-Hermelink, HK; Müller, RP; Engert, A; J Clin Oncol. 2010; 28(27): 4199-4206.

A correlation of endocrine and anticancer effects of some antagonists of GHRH

Kovacs, M; Schally, AV; Hohla, F; Rick, FG; Pozsgai, E; Szalontay, L; Varga, JL; Zarandi, M PEPTIDES. 2010; 31(10): 1839-1846.

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.

Asslaber, D; Piñón, JD; Seyfried, I; Desch, P; Stöcher, M; Tinhofer, I; Egle, A; Merkel, O; Greil, R; Blood. 2010; 115(21):4191-4197

Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.

Merkel, O; Hamacher, F; Laimer, D; Sifft, E; Trajanoski, Z; Scheideler, M; Egger, G; Hassler, MR; Thallinger, C; Schmatz, A; Turner, SD; Greil, R; Kenner, L; Proc Natl Acad Sci U S A. 2010; 107(37):16228-16233

Reduced treatment intensity in patients with early-stage Hodgkin“s lymphoma.

Engert, A; Plütschow, A; Eich, HT; Lohri, A; Dörken, B; Borchmann, P; Berger, B; Greil, R; Willborn, KC; Wilhelm, M; Debus, J; Eble, MJ; Sökler, M; Ho, A; Rank, A; Ganser, A; Trümper, L; Bokemeyer, C; Kirchner, H; Schubert, J; Král, Z; Fuchs, M; Müller-Hermelink, HK; Müller, RP; Diehl, V; N Engl J Med. 2010; 363(7): 640-652.